MORGAN STANLEY PLC/PUT/STRYKER CORP./250/0.1/20.09.24 Stock

Warrant

DE000ME184P1

Market Closed - Börse Stuttgart 11:46:45 2024-07-16 am EDT
0.12 EUR -4.76% Intraday chart for MORGAN STANLEY PLC/PUT/STRYKER CORP./250/0.1/20.09.24
1 month+11.11%
3 months-40.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.12 -4.76%
24-07-15 0.126 +5.88%
24-07-12 0.119 -3.25%
24-07-11 0.123 -8.89%
24-07-10 0.135 +9.76%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 11:46 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME184P
ISINDE000ME184P1
Date issued 2023-09-27
Strike 250 $
Maturity 2024-09-20 (65 Days)
Parity 10 : 1
Emission price 1.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.09
Lowest since issue 0.03
Spread 0.066
Spread %37.50%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.6 USD
Average target price
372.7 USD
Spread / Average Target
+11.39%
Consensus